OR WAIT null SECS
Waters Corporation and Northeastern University opened the doors of the Waters Mass Spectrometry Laboratory within the renowned Barnett Institute of Chemical and Biological Analysis at the University.
Waters Corporation (NYSE:WAT) and Northeastern University today opened the doors of the new Waters Mass Spectrometry Laboratory within the renowned Barnett Institute of Chemical and Biological Analysis at the University. The new laboratory is dedicated to studying protein shapes and characteristics to provide pharmaceutical and biotechnology innovators with the tools necessary to develop new treatment options for some of the world?s deadiest diseases, like AIDS and cancer.
?There are people all over the world working on all different aspects of this kind of research,? said John R. Engen, associate professor of chemistry and chemical biology and faculty fellow at the Institute. ?What we intend to do is add a piece to the puzzle that will help researchers, scientists and doctors better understand these diseases and, ultimately, treat and cure them.??The Barnett Institute is very grateful to Waters for its generous support,? said Barry L. Karger, the James L. Waters chair in analytical chemistry and director of the Barnett Institute. ?This cutting-edge facility will enhance the important work of Professor Engen and of the Institute as a whole.?As a demonstration of commitment, Douglas A. Berthiaume, Chairman, President and CEO of Waters Corporation, led a delegation of senior Waters executives, including Art Caputo, Executive Vice President and President of Waters Division, and James L. Waters, founder of Waters Corporation, at the laboratory opening ceremony hosted by Northeastern University. ?Waters has built its understanding of proteomics over nearly 50 years of experience developing and providing scientists with innovative compound separation techniques for laboratories around the world,? said Caputo. ?Northeastern University?s focus on protein research and analysis to understand disease mechanisms at the molecular level is critical to the success in formulating new treatment options. Ultimately, we hope research from the new Waters Mass Spectrometry Laboratory at Northeastern University will produce the knowledge needed to cure the world?s deadly diseases.?